 | • レポートコード：MRC2303H216 • 出版社/出版日：360iResearch / 2022年10月11日 • レポート形態：英語、PDF、228ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査資料によると、2021年に219.2百万ドルであった世界の腎デナベーションデバイス市場規模は2022年に296.12百万ドルとなり、2027年までに年平均35.32％成長して1,346.56百万ドルまで拡大すると見込まれています。当書は、腎デナベーションデバイスの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別分析（マイクロインフュージョン式、薬理学的アブレーション式、高周波式、超音波式）、製品別分析（カテーテル、マルチ電極カテーテル、神経変性剤、RFジェネレータ、単極カテーテル）、疾患別分析（糖尿病、心不全、高血圧症、腎不全）、エンドユーザー別分析（外来手術センター、診断センター＆病院、研究＆学術機関）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書内の企業情報としては、Abbott Laboratories、Ablative Solutions, Inc.、Bioscience Webster Inc.、Boston Scientific Corporation、CardioSonic, Inc.、Cordis Corporation、Covidien PLC、Hansen Medical, Inc.、Johnson & Johnson、Kona Medical, Inc.、Medtronic PLCなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の腎デナベーションデバイス市場規模：技術別 - マイクロインフュージョン式腎デナベーションデバイスの市場規模 - 薬理学的アブレーション式腎デナベーションデバイスの市場規模 - 高周波式腎デナベーションデバイスの市場規模 - 超音波式腎デナベーションデバイスの市場規模 ・世界の腎デナベーションデバイス市場規模：製品別 - カテーテルの市場規模 - マルチ電極カテーテルの市場規模 - 神経変性剤の市場規模 - RFジェネレータの市場規模 - 単極カテーテルの市場規模 ・世界の腎デナベーションデバイス市場規模：疾患別 - 糖尿病における市場規模 - 心不全における市場規模 - 高血圧症における市場規模 - 腎不全における市場規模 ・世界の腎デナベーションデバイス市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 診断センター＆病院における市場規模 - 研究＆学術機関における市場規模 ・世界の腎デナベーションデバイス市場規模：地域別 - 南北アメリカの腎デナベーションデバイス市場規模 アメリカの腎デナベーションデバイス市場規模 カナダの腎デナベーションデバイス市場規模 ブラジルの腎デナベーションデバイス市場規模 ... - アジア太平洋の腎デナベーションデバイス市場規模 日本の腎デナベーションデバイス市場規模 中国の腎デナベーションデバイス市場規模 インドの腎デナベーションデバイス市場規模 韓国の腎デナベーションデバイス市場規模 台湾の腎デナベーションデバイス市場規模 ... - ヨーロッパ/中東/アフリカの腎デナベーションデバイス市場規模 イギリスの腎デナベーションデバイス市場規模 ドイツの腎デナベーションデバイス市場規模 フランスの腎デナベーションデバイス市場規模 ロシアの腎デナベーションデバイス市場規模 ... - その他地域の腎デナベーションデバイス市場規模 ・競争状況 ・企業情報 |
The Global Renal Denervation Devices Market size was estimated at USD 219.22 million in 2021 and expected to reach USD 296.12 million in 2022, and is projected to grow at a CAGR 35.32% to reach USD 1,346.56 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Renal Denervation Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Micro-infusion-based, Pharmacologic Ablation, Radiofrequency-based, and Ultrasound-based.
Based on Products, the market was studied across Catheters, Multi Electrode Catheter, Nerve Modifying Agents, RF Generator, and Single Electrode Catheter.
Based on Disease Application, the market was studied across Diabetes, Heart failure, Hypertension, and Renal failure.
Based on End User, the market was studied across Ambulatory Care Centers, Diagnostic Centers & Hospitals, and Research & academia.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Renal Denervation Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Renal Denervation Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Renal Denervation Devices Market, including Abbott Laboratories, Ablative Solutions, Inc., Bioscience Webster Inc., Boston Scientific Corporation, CardioSonic, Inc., Cordis Corporation, Covidien PLC, Hansen Medical, Inc., Johnson & Johnson, Kona Medical, Inc., Medtronic PLC, Mercator Medsystems, Inc., Recor Medical, Inc., Renal Dynamics LLC, SoniVie Ltd., St. Jude Medical, Inc., Symple Surgical, Inc., and Terumo Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Renal Denervation Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Renal Denervation Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Renal Denervation Devices Market?
4. What is the competitive strategic window for opportunities in the Global Renal Denervation Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Renal Denervation Devices Market?
6. What is the market share of the leading vendors in the Global Renal Denervation Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Renal Denervation Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of congestive heart failure, diabetes, and chronic renal failure
5.1.1.2. Growing adoption of minimally invasive surgical procedures
5.1.1.3. Increasing geriatric population with resistant hypertension
5.1.2. Restraints
5.1.2.1. Limited efficacy of renewal denervation devices
5.1.3. Opportunities
5.1.3.1. Emergence of state-of-art RDN devices
5.1.3.2. Favorable reimbursement policies
5.1.4. Challenges
5.1.4.1. Lack of trained and experienced healthcare professionals
5.2. Cumulative Impact of COVID-19
6. Renal Denervation Devices Market, by Technology
6.1. Introduction
6.2. Micro-infusion-based
6.3. Pharmacologic Ablation
6.4. Radiofrequency-based
6.5. Ultrasound-based
7. Renal Denervation Devices Market, by Products
7.1. Introduction
7.2. Catheters
7.3. Multi Electrode Catheter
7.4. Nerve Modifying Agents
7.5. RF Generator
7.6. Single Electrode Catheter
8. Renal Denervation Devices Market, by Disease Application
8.1. Introduction
8.2. Diabetes
8.3. Heart failure
8.4. Hypertension
8.5. Renal failure
9. Renal Denervation Devices Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Diagnostic Centers & Hospitals
9.4. Research & academia
10. Americas Renal Denervation Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Renal Denervation Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Renal Denervation Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Ablative Solutions, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Bioscience Webster Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Boston Scientific Corporation
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. CardioSonic, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Cordis Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Covidien PLC
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Hansen Medical, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Johnson & Johnson
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Kona Medical, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Medtronic PLC
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Mercator Medsystems, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Recor Medical, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Renal Dynamics LLC
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. SoniVie Ltd.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. St. Jude Medical, Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Symple Surgical, Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Terumo Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing